|
Liu, Z; Wong, J T (1999) Proliferative and regenerative capacities of CD4(+) T cells upon TCR stimulation. Clin Immunol 93:16-23
|
|
Shankar, P; Xu, Z; Lieberman, J (1999) Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 94:3084-93
|
|
Trimble, L A; Xu, Z; Lieberman, J (1999) Clonal expansion of antigen-specific CD8+ cytotoxic T lymphocytes is regulated by late exposure to serum to prevent apoptosis. J Immunol Methods 225:39-52
|
|
Trimble, L A; Lieberman, J (1998) Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 91:585-94
|
|
D'Aquila, R T; Sutton, L; Savara, A et al. (1998) CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology Team. J Infect Dis 177:1549-53
|
|
Lieberman, J; Skolnik, P R; Parkerson 3rd, G R et al. (1997) Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood 90:2196-206
|
|
Roberts, C G; Meister, G E; Jesdale, B M et al. (1996) Prediction of HIV peptide epitopes by a novel algorithm. AIDS Res Hum Retroviruses 12:593-610
|
|
Buchsbaum, R J; Fabry, J A; Lieberman, J (1996) EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice. Immunol Lett 52:145-52
|
|
Angel, J B; Saget, B M; Walsh, S P et al. (1995) Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS 9:1137-44
|
|
Wilson, C C; Wong, J T; Girard, D D et al. (1995) Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J Infect Dis 172:88-96
|
Showing the most recent 10 out of 12 publications
